Skip to main content

Table 3 Details in prosthetic valves

From: Early and mid-term outcomes after aortic valve intervention in patients with previous stentless or stented bioprostheses

Variable

N—Stented

Stat—Stented

N—Stentless

Stat—Stentless

P value

Type of explanted prosthesis

100

 

12

 

 < 0.001

 Carpentier-Edwards Pericardial

 

7 (7%)

 

0 (0%)

 

 Carpentier-Edwards Pericardial

 

24 (24%)

 

0 (0%)

 

 Epic

 

1 (1%)

 

0 (0%)

 

 Freestyle stentless

 

0 (0%)

 

4 (33%)

 

 Hancock II Porcine

 

54 (54%)

 

0 (0%)

 

 Magna Pericardial

 

2 (2%)

 

0 (0%)

 

 Mitroflow

 

3 (3%)

 

0 (0%)

 

 Mosaic

 

8 (8%)

 

0 (0%)

 

 Toronto Stentless Porcine

 

0 (0%)

 

8 (67%)

 

 Trifecta

 

1 (1%)

 

0 (0%)

 

Type of prosthesis implanted in current procedure

100

 

12

 

< 0.001

 Carpentier-Edwards Pericardial

 

7 (7%)

 

0 (0%)

 

 Carpentier-Edwards Perimount Magna Ease

 

0 (0%)

 

1 (8%)

 

 Epic

 

1 (1%)

 

0 (0%)

 

 Freestyle Stentless

 

11 (11%)

 

1 (8%)

 

 Hancock II Porcine

 

37 (37%)

 

1 (8%)

 

 Homograft

 

5 (5%)

 

0 (0%)

 

 Magna Pericardial

 

6 (6%)

 

1 (8%)

 

 Medtronic Hancock II Aortic Cinch

 

0 (0%)

 

1 (8%)

 

 Mosaic

 

3 (3%)

 

0 (0%)

 

 St-Jude

 

26 (26%)

 

0 (0%)

 

 St. Jude HP Aortic Valved Graft

 

0 (0%)

 

1 (8%)

 

 St.Jude Aortic Valved Graft

 

0 (0%)

 

1 (8%)

 

 Trans-catheter-Apical

 

4 (4%)

 

1 (8%)

 

 Trans-catheter-Femoral

 

0 (0%)

 

4 (33%)